1. Combs, D. W. (1992): Alkyl (benzoxazinyl) pyridazines [(+)-bemoradan and (−)-bemoradan], a process for their preparation and their use as cardiotonic agents. EP 509845. CAN 118: 101973.
2. Combs, D. W., Rampulla, M. S., Bell, S. C., Klaubert, D. H., Tobia, A. J., Falotico, R., Haertlein, B., Lakas-Weiss, C., Moore, J. B. (1990): 6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents. J. Med. Chem., 33(1), 380–6.
3. Combs, D. W., Rampulla, M. S., Demers, J. P., Falotico, R., Moore, J. B., (1992). Heteroatom analogs of bemoradan: chemistry and cardiotonic activity of 1,4-benzothiazinylpyridazinones. J. Med. Chem., 35(1), 172–6.
4. Falotico, R., Haerlein, B., Lakas-Weiss, C., Giardino, E., Salata, J., Combs, D., Bell, S., Tobia, A. (1989): Positive inotropic and peripheral vasodilator activity of Bemoradan: a potent, long acting, orally effective cardiotonic agent, (The Federation of American Society for Experimental Biology Meeting), The FASEB J., 3: 4731.
5. Moore, J. B., Miller, W. C., Falotico, R., Combs, D., Tobia, A. (1989): Inhibition of canine cardiac cyclic AMP phosphodiesterase by bemoradan — a novel positive inotropic agent. (The Federation of American Society for Experimental Biology Meeting). The FASEB J., 3: 4730.